At Evotec, infectious disease research is built on innovation and efficiency, driven by expert scientists. We leverage our extensive ID knowledge with Evotec’s advanced R&D platforms to address new antibacterial therapy challenges. Our sophisticated in vitro and in vivo capabilities, supported by a dedicated bioinformatics team and hollow fibre technology expertise, enable comprehensive support for infectious disease projects. Our experienced teams collaborate closely with yours, merging antibacterial expertise with Evotec’s platforms to deliver optimal solutions for antibacterial programs, ensuring smooth progress from research to clinical application.